top of page

Disease areas of focus

Our Progress by Disease Area


- We currently are working on 16 disease areas that have all been patented, archived in an international depositary and successfully completed pilot studies & toxicology tests.

- Several of our disease areas have progressed further and have initiated or completed their pre-clinical trial phase.

Legal Structure:

All disease areas projects are structured as a separate subsidiary of the parent company Cell & Gene Therapy ltd, allowing each project to separate its intellectual property. 

- This makes it possible for investors to invest into a specific disease area project if they wish to, rather than the entire parent company

Partnerships & Alliances:

- We are currently looking to build alliances & partnerships with potential investors to progress our disease area projects accross our portfolio

- If you are interested in this opportunity then you can contact us here.

bottom of page